CRM
65
6
F
38
4
PH
60
5
HSY
32
3
UPS
51
6
HP
44
14
NKE
36
2
CNX
67
4
PCG
59
9
HCP
54
2
DNB
72
4
UNP
38
5
GOOGL
62
6
RCL
74
5
AMAT
33
3
EFX
43
3
MS
64
3
UNH
42
6
KLAC
45
3
ZBH
69
15
CRM
65
6
F
38
4
PH
60
5
HSY
32
3
UPS
51
6
HP
44
14
NKE
36
2
CNX
67
4
PCG
59
9
HCP
54
2
DNB
72
4
UNP
38
5
GOOGL
62
6
RCL
74
5
AMAT
33
3
EFX
43
3
MS
64
3
UNH
42
6
KLAC
45
3
ZBH
69
15
Financhill
Back

Teva Pharmaceutical Industries 10K Form

Buy
65

TEVA
Teva Pharmaceutical Industries

Last Price:
$22.09
Seasonality Move:
6.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q TEVA/Teva Pharmaceutical Industries Quarterly
2024-02-12 10K TEVA/Teva Pharmaceutical Industries Annual
2023-11-09 10Q TEVA/Teva Pharmaceutical Industries Quarterly
2023-08-02 10Q TEVA/Teva Pharmaceutical Industries Quarterly
2023-05-10 10Q TEVA/Teva Pharmaceutical Industries Quarterly
2023-02-10 10K TEVA/Teva Pharmaceutical Industries Annual

Receive TEVA News And Ratings

See the #1 stock for the next 7 days that we like better than TEVA

TEVA Financial Statistics

Sales & Book Value

Annual Sales: $15.8B
Cash Flow: $545M
Price / Cash Flow: 18.2
Annual Sales: $5.35
Price / Book: 4.13

Profitability

EPS (TTM): -0.85000
Net Income (TTM): $-959M
Gross Margin: $7.6B
Return on Equity: -13.27%
Return on Assets: -2.27%

Teva Pharmaceutical Industries Earnings Forecast

Key Teva Pharmaceutical Industries Financial Ratios

  • The Gross Profit Margin over the past 38 years for TEVA is 48.25%.
  • The Selling, General & Administrative Expenses for TEVA have been equal to 22.08% of Gross Profit Margin.
  • The Research & Development expenses have been 6.01% of Revenue.
  • The Interest Expense is -184.08% of Operating Income.
  • The Net Earning history of TEVA is -3.53% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 24 years.

Teva Pharmaceutical Industries Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TEVA
CUSIP: 881624
Website: tevapharm.com

Debt

Debt-to-Equity Ratio: 3.13
Current Ratio: 0.89
Quick Ratio: 0.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 7.86

TEVA Technical Analysis vs Fundamental Analysis

Buy
65
Teva Pharmaceutical Industries (TEVA) is a Buy

Is Teva Pharmaceutical Industries a Buy or a Sell?